EMEA-000713-PIP02-10-M05
Key facts
Invented name |
Pixuvri
|
Active substance |
pixantrone dimaleate
|
Therapeutic area |
Oncology
|
Decision number |
P/0227/2018
|
PIP number |
EMEA-000713-PIP02-10-M05
|
Pharmaceutical form(s) |
Powder for concentrate for solution for infusion
|
Condition(s) / indication(s) |
Treatment of non-Hodgkin lymphoma
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
CTI Life Sciences Limited
Tel. +1 2062724260 |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|